Walsh & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Walsh & Associates's MRK Position: Q3 2026 in Review
Walsh & Associates opened a new position in Merck (MRK) in Q3 2026: 25 shares worth $3.63K. The stake represents ﹤0.01% of the portfolio and ranks #230 among its holdings. This is a return to the name: Walsh & Associates previously reported a position in MRK as recently as Q1 2026.
Walsh & Associates first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. 3,977 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Walsh & Associates held 25 shares of Merck worth $3.63K as of Q3 2026.
- Merck was a new Walsh & Associates position in Q3 2026.
- Merck made up ﹤0.01% of Walsh & Associates's portfolio in Q3 2026, its #230 holding.
- Walsh & Associates first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
- 3,977 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.